WatchPAT 300
Itamar Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPAT™ 300
March 20, 2019 09:00 ET | Itamar Medical
Latest WatchPAT innovation improves patient comfort and simplifies physician workflow CAESAREA, Israel, March 20, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq & TASE: ITMR), a...
Itamar.png
Itamar Medical Reports Fourth Quarter and Full Year 2018 Financial Results With Record Revenues
March 13, 2019 06:00 ET | Itamar Medical
Full Year 2018 Revenues Increased 17% to $24.2 Million; WatchPAT™ Revenues Increased 24% to $22.4 Million Fourth Quarter 2018 Revenues Increased 9% to $6.6 Million; WatchPAT Revenues Increased 19% to...
Itamar.png
Itamar Medical to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
March 12, 2019 09:00 ET | Itamar Medical
CAESAREA, Israel, March 12, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical device company that develops, manufactures and markets non-invasive diagnostic medical...
Itamar.png
Itamar Medical to Commence Trading on Nasdaq
February 27, 2019 10:15 ET | Itamar Medical
Will Trade on both Nasdaq and TASE under the Ticker Symbol ‘ITMR’ CAESAREA, Israel, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical device company that...
Itamar.png
Itamar Medical Announces that Publication on the Role of Obstructive Sleep Apnea in Atrial Fibrillation Selected for Inclusion in Circulation’s 2018 Year in Review
February 14, 2019 09:00 ET | Itamar Medical
Selection as one of the most prominent and important articles of 2018 reflects significant contribution to advancing cardiovascular health CAESAREA, Israel, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Itamar...
Itamar.png
Itamar Medical Partners with CardioVisual to Educate Patients and Healthcare Providers on the Importance of Sleep Apnea Testing and Streamline Cardiology Practice Workflow
February 07, 2019 09:00 ET | Itamar Medical
CAESAREA, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (TASE: ITMR), a medical technology company that designs, develops, manufactures and sells sleep apnea diagnostic ambulatory...
Itamar.png
Itamar Medical Announces Definitive Agreements for $11.5 Million Private Placement
January 17, 2019 09:00 ET | Itamar Medical
CAESAREA, Israel, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep apnea with...
Itamar.png
Itamar Medical Reports Record Third Quarter 2018 Financial Results
November 27, 2018 09:00 ET | Itamar Medical
Third Quarter 2018 Highlights: Achieved 14.7% increase in third-quarter revenue to a record $6.1 millionU.S. revenues increased 29% compared with third quarter 2017Gross profit remained strong at...
Itamar.png
Itamar Medical Announces Favorable CMS Reimbursement Decision to its WatchPAT™ Sleep Apnea Testing Device
November 08, 2018 09:00 ET | Itamar Medical
CAESAREA, Israel, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep-apnea with...
Itamar.png
Itamar Medical Reports Second Quarter 2018 Financial Results
August 13, 2018 08:00 ET | Itamar Medical
Second Quarter 2018 Highlights: Achieved 20% increase in revenue to a record $6 million Recurring revenue represents 67% of revenue in North AmericaMaintained gross profit of 76% of total revenueCash...